tuberculosis

Running Away from TB Treatment

Twenty-three-year-old Haleema (not her real name) was not the first female patient at Srinagar’s Chest Diseases Hospital in the Indian state of Kashmir to try to run away.

Doctors in Argentina Sound the Alert on Vaccine Sceptics

Argentina is one of the countries in Latin America with the highest levels of vaccination coverage. But experts are concerned about the growing campaign by vaccine critics against immunisation.

U.S. Global Health Cuts Threaten Gains on Lethal Diseases

A U.S.-based civil society coalition is calling on Congress and President Barack Obama’s administration to keep spending on global health aid at current levels, warning that recent budget cuts risk a dangerous backslide in health and development gains achieved over the past three decades.

Universities “Not Living up to Missions” on Global Health Research

A first-time ranking of 54 top research universities in the United States and Canada has found that a miniscule percentage of funding goes to neglected diseases, despite the outsized influence that public universities play in developing medicines for illnesses often ignored by the private sector.

Advocates See Historic Chance to Turn Tide on TB

Patients, doctors and international aid groups are calling on donors and governments to support measures that would make treatment of drug-resistant tuberculosis more effective and accessible.

TB_bacterium_400

Controversial Anti-TB Drug Approved in U.S.

The U.S. Food and Drug Administration (FDA), the sector’s primary regulator, has given accelerated approval to a controversial new drug for use by patients suffering from forms of tuberculosis that have proven resistant to other medicines.

CMCorrea

Will There Finally Be a Cure for Diseases that Affect the Poor?

Innovation in the pharmaceutical industry has declined drastically in the last ten years despite the high profitability of the so-called "research-based" industry, and the availability of better and more powerful science and technological tools. Not only has productivity in terms of research fallen, but the vast majority of new molecules introduced to the market do not provide new therapeutic solutions since other treatments already exist, normally at a lower cost.

Lead Funder on AIDS, Malaria, TB Gets a Reboot

After weathering the departure of its executive director amidst a misallocation scandal earlier this year, the world's largest funder of programmes to address HIV/AIDS, tuberculosis and malaria is poised to announce a new leader Thursday.

In TB Fight, It’s ‘Pay Now or Pay Later’

The next several years could see either the elimination of tuberculosis in some regions or millions of otherwise preventable deaths, according to new research released in Washington Wednesday by the World health Organisation (WHO).